Clinical Trial Update: Study Using FolateScan to Identify Subjects With Folate Receptor-Positive Metastatic Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating FolateScan to identify subjects with folate receptor-positive metastatic renal cell carcinoma; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Endocyte | Conditions: Metastatic Renal Cell Carcinoma | Phase 2 | Status: COMPLETED